Amalgamated Bank Trevena Inc Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.5 $4,448 - $11,121	-22,242 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.41 - $0.63 $657 - $1,009	-1,603 Reduced 6.72%	22,242 $12,000
Q4 2021 Feb 15, 2022	SELL	$0.57 - $1.29 $469 - $1,062	-824 Reduced 3.34%	23,845 $14,000
Q3 2021 Oct 29, 2021	SELL	$1.11 - $1.7 $1,107 - $1,696	-998 Reduced 3.89%	24,669 $30,000
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.25 $37,473 - $57,750	25,667 New	25,667 $43,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $292M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.